AstraZeneca
Top Ten most popular articles on Pharmafile.com this week
December 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10
With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …
AstraZeneca and Oxford Uni vaccine is safe and effective in preventing COVID-19 infection, Phase 3 data show
December 9, 2020Research and Development AstraZeneca, COVID-19, Vaccine
The latest efficacy data on the COVID-19 vaccine developed by AstraZeneca in partnership with the University of Oxford have been …
NICE recommendation for AstraZeneca’s Calquence in chronic lymphocytic leukaemia populations
December 8, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, NHS, NICE, UK, leukaemia
The National Institute for Health and Care Excellence (NICE) has recommended that AstraZeneca’s Calquence (acalabrutinib) be used on the NHS in …
Grünenthal buys European rights to AstraZeneca’s Crestor for a potential $350m
December 1, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, Crestor, Grunenthal
Grünenthal has picked up AstraZeneca’s statin therapy Crestor (rosuvastatin), currently approved in dyslipidaemia and hypercholesterolaemia treatment, in a deal worth …
Japan approves AstraZeneca’s Forxiga for chronic heart failure
November 30, 2020Sales and Marketing AstraZeneca, Forxiga
Japan’s Ministry of Health, Labour and Welfare (MHLW) has announced the authorisation of AstraZeneca’s Forxiga as a treatment for chronic …
Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses
November 26, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …
Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy
November 23, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine
Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …
AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients
November 12, 2020Business Services AZ, AstraZeneca, Calquence
AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19. Calquence (acalabrutinib) is …
Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni
November 9, 2020Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine
AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data
November 9, 2020Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma
AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …
AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal
October 30, 2020Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm
AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants
October 26, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine
AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …
Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine
October 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine
AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …
FDA grants priority review to AstraZeneca’s Tagrisso as an adjuvant for early-stage EGFR-mutated non-small cell lung cancer
October 20, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Tagrisso
The FDA has revealed its decision to grant Priority Review to AstraZeneca’s Tagrisso (osimertinib) as an adjuvant treatment of patients …
European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine
October 9, 2020Medical Communications AZ, AstraZeneca, Janssen
The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
